The reemergence of dengue virus serotype 3 (DENV-3) in Brazil after 17 years could help worsen fresh outbreaks of the disease ...

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

The illness typically lasts two to seven days, but severe cases can be deadly. An affected person will have flu-like symptoms ...

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

A research team has unveiled new insights into how weather influences the spread of dengue fever. The study identifies temperature and rainfall as critical factors driving the global surge in dengue ...

Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.